UMB Bank N A MO Invests $201,000 in Waters Co. (NYSE:WAT)


Share on StockTwits

UMB Bank N A MO purchased a new position in shares of Waters Co. (NYSE:WAT) during the first quarter, HoldingsChannel.com reports. The institutional investor purchased 708 shares of the medical instruments supplier’s stock, valued at approximately $201,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Norges Bank acquired a new position in Waters in the fourth quarter worth $128,787,000. Los Angeles Capital Management LLC grew its holdings in Waters by 892.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 285,876 shares of the medical instruments supplier’s stock worth $70,731,000 after acquiring an additional 257,061 shares during the last quarter. Nordea Investment Management AB increased its position in Waters by 24.6% in the 4th quarter. Nordea Investment Management AB now owns 952,632 shares of the medical instruments supplier’s stock valued at $235,700,000 after acquiring an additional 187,823 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Waters by 135.7% in the fourth quarter. Wells Fargo & Company MN now owns 298,222 shares of the medical instruments supplier’s stock worth $73,786,000 after acquiring an additional 171,719 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its position in shares of Waters by 194.6% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 248,460 shares of the medical instruments supplier’s stock worth $61,471,000 after purchasing an additional 164,122 shares in the last quarter. 91.80% of the stock is owned by hedge funds and other institutional investors.

In related news, Director Joann A. Reed sold 1,600 shares of the firm’s stock in a transaction on Friday, March 5th. The shares were sold at an average price of $263.31, for a total transaction of $421,296.00. Also, Director Joann A. Reed sold 4,759 shares of the firm’s stock in a transaction on Tuesday, February 9th. The stock was sold at an average price of $282.39, for a total transaction of $1,343,894.01. Following the sale, the director now owns 36,683 shares in the company, valued at $10,358,912.37. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.

Shares of NYSE WAT opened at $296.27 on Wednesday. The company’s fifty day moving average is $281.99 and its 200-day moving average is $254.50. The stock has a market cap of $18.39 billion, a price-to-earnings ratio of 36.90, a P/E/G ratio of 8.79 and a beta of 0.97. Waters Co. has a twelve month low of $171.38 and a twelve month high of $309.65.

Waters (NYSE:WAT) last announced its quarterly earnings results on Monday, February 1st. The medical instruments supplier reported $3.65 earnings per share for the quarter, topping analysts’ consensus estimates of $2.89 by $0.76. The company had revenue of $786.66 million for the quarter, compared to analysts’ expectations of $711.10 million. Waters had a net margin of 22.61% and a negative return on equity of 349.31%. During the same period last year, the firm posted $3.20 earnings per share. As a group, analysts forecast that Waters Co. will post 7.94 EPS for the current fiscal year.

WAT has been the subject of a number of research reports. Wells Fargo & Company lowered shares of Waters from an “equal weight” rating to an “underweight” rating and set a $235.00 price target for the company. in a report on Thursday, January 7th. TheStreet raised shares of Waters from a “c” rating to an “a-” rating in a report on Tuesday, February 2nd. Finally, Citigroup raised their price target on shares of Waters from $250.00 to $300.00 in a report on Wednesday, February 3rd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $225.27.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Article: What is the Book Value of a Share?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.